Literature DB >> 8809782

Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves.

R Wagner1, R R Myers.   

Abstract

We investigated the production of tumor necrosis factor alpha, a pleotropic cytokine, in the rat sciatic nerve using immunohistochemistry for the protein and in situ hybridization for specific messenger RNA sequences. Results demonstrated that in the uninjured sciatic nerve, few endothelial cells, fibroblasts, and Schwann cells were immunoreactive for tumor necrosis factor. In situ hybridization did not yield visible results in this control tissue. Following a compression injury, the number of immunoreactive cells in the nerve fascicle was increased. In situ hybridization showed positive staining in Schwann cells and endothelial cells at seven days. These observations are the first to demonstrate the production of this proinflammatory cytokine by peripheral nerve glia, and further support other studies from this laboratory suggesting that tumor necrosis factor has a pathogenic role in nerve injury. Because this cytokine is produced by Schwann cells in intimate contact with nerve fibers, tumor necrosis factor may also have a role in the hyperalgesia associated with neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8809782     DOI: 10.1016/0306-4522(96)00127-3

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  82 in total

1.  Etanercept attenuates pain-related behavior following compression of the dorsal root ganglion in the rat.

Authors:  Kazuyuki Watanabe; Shoji Yabuki; Miho Sekiguchi; Shin-ichi Kikuchi; Shin-ichi Konno
Journal:  Eur Spine J       Date:  2011-06-02       Impact factor: 3.134

Review 2.  New and emerging pharmacological targets for neuropathic pain.

Authors:  Donald C Manning
Journal:  Curr Pain Headache Rep       Date:  2004-06

3.  The fusion of bone-marrow-derived proinsulin-expressing cells with nerve cells underlies diabetic neuropathy.

Authors:  Tomoya Terashima; Hideto Kojima; Mineko Fujimiya; Kazuhiro Matsumura; Jiro Oi; Manami Hara; Atsunori Kashiwagi; Hiroshi Kimura; Hitoshi Yasuda; Lawrence Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-22       Impact factor: 11.205

4.  Up-regulation of TNFalpha in DRG satellite cells following lumbar facet joint injury in rats.

Authors:  Masayuki Miyagi; Seiji Ohtori; Tetsuhiro Ishikawa; Yasuchika Aoki; Tomoyuki Ozawa; Hideo Doya; Tomoko Saito; Hideshige Moriya; Kazuhisa Takahashi
Journal:  Eur Spine J       Date:  2006-04-29       Impact factor: 3.134

5.  Pattern VEP alterations in psoriatic patients may indicate a sub clinic optic neuritis.

Authors:  M Perossini; E Turio; T Perossini; M Romagnoli; S Benedetti; G Cei; P Barachini; M Nardi
Journal:  Doc Ophthalmol       Date:  2005 Mar-May       Impact factor: 2.379

Review 6.  [Cytokine regulation and pain. Results of experimental and clinical research].

Authors:  N Uçeyler; C Sommer
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

7.  TNFalpha-induced MMP-9 promotes macrophage recruitment into injured peripheral nerve.

Authors:  Veronica I Shubayev; Mila Angert; Jennifer Dolkas; W Marie Campana; Kai Palenscar; Robert R Myers
Journal:  Mol Cell Neurosci       Date:  2005-11-16       Impact factor: 4.314

8.  Wallerian degeneration in C57BL/6J and A/J mice: differences in time course of neurofilament and myelin breakdown, macrophage recruitment and iNOS expression.

Authors:  Cristiane L R de la Hoz; Alexandre L R Oliveira; Luciano de S Queiroz; Francesco Langone
Journal:  J Anat       Date:  2003-12       Impact factor: 2.610

9.  Role of mitogen-activated protein kinase cascades in inducible nitric oxide synthase expression by lipopolysaccharide in a rat Schwann cell line.

Authors:  Haibo Wang; Chun Cheng; Yongwei Qin; Shuqiong Niu; Shangfeng Gao; Xin Li; Tao Tao; Aiguo Shen
Journal:  Neurochem Res       Date:  2008-07-31       Impact factor: 3.996

10.  A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injury.

Authors:  Wei-Ping Wu; Jing-Xia Hao; Ennio Ongini; Francesco Impagnatiello; Cristina Presotto; Zsuzsanna Wiesenfeld-Hallin; Xiao-Jun Xu
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.